Recent News

• 03.12.2026 - Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
• 03.04.2026 - Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
• 02.19.2026 - Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026
• 11.06.2025 - Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025
• 10.31.2025 - Stevanato Group to Participate in Upcoming Investor Conferences

Recent Filings

• 03.04.2026 - EX-99.1 EX-99.1
• 03.04.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.04.2026 - EX-99.1 EX-99.1
• 03.04.2026 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.04.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.03.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.09.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 12.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.18.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.18.2025 - EX-99.1 EX-99.1